AAOHN 2017 Annual Conference

419 - Hot Topics: Biohazard Agents, Robotics in the Workplace & Safety and Effectiveness of Combined Cellular Therapy for the Treatment of Pain and Function Associated with Osteoarthritis

Apr 25, 2017 1:30pm ‐ Apr 25, 2017 3:00pm

Credits: None available.

Standard: $50.00


Nanotechnology, specifically nanomedicine and nanorobotics has emerged as one of the most exciting combined fields in medicine, science and engineering. Nanomedicine and nanorobotics will change the landscape of work, chronic disease management, health-coaching, and health education. Learn about the safety and effectiveness of Combined Cellular Therapy (bone marrow aspirate concentrate (BMAC), platelet-rich plasma (PRP) and fat graft) for the treatment of pain and function associated with osteoarthritis. You’ll also examine case studies of Zika, Tularemia, Eastern equine encephalitis virus, and non- human primate herpes B to discuss evaluation and treatment.

  • Discuss the evaluation/treatment and follow up for three biohazardous agents.
  • Discuss leading edge technology and scientific discoveries in the field of nanomedicine and nanorobotics and implications for the occupational health nurse.
  • Discuss the findings of a study assessing the clinical outcome of participants receiving a combination of bone marrow aspirate concentrate (BMAC) mesenchymal stem cells, adipose tissue (fat graft), and platelet-rich plasma (PRP) for the treatment of osteoarthritis.



  • 1.50 - CNE

You must be logged in and own this session in order to post comments.